All three PBMs are associated with the country's three largest health insurers and are accused of boosting prices of specialty generic drugs through their own pharmacies, generating more than $7.3 billion in revenue.
On their way out the door, the Biden administration's Federal Trade Commission (FTC) released another highly critical...National News
Following a contentious summer between regulators and pharmacy benefit managers (PBMs), the Cigna subsidiary ExpressScripts has now sued the Federal Trade Commission (FTC) and demands it retract a July report that found the three largest PBMs place profits over patients.
The FTC report, which is the culmination of a federal probe into...
